RecruitingNCT00556530
Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome
Genetic Modifiers of 22q11.2 Deletion Syndrome
Sponsor
Albert Einstein College of Medicine
Enrollment
1,000 participants
Start Date
Jul 1, 2016
Study Type
OBSERVATIONAL
Conditions
Summary
22q11.2 deletion syndrome is a genetic disorder that can cause heart defects, facial abnormalities, and developmental and learning disabilities. The severity of the disorder can vary widely among people. This study will analyze DNA from people with 22q11.2 deletion syndrome to identify genetic variations that may affect the severity of the disorder.
Eligibility
Inclusion Criteria1
- Has 22q11 deletion of 3 megabases (Mb)
Exclusion Criteria1
- Has 22q11 deletion smaller than 3 Mb or no deletion
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT00556530
Related Trials
Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)
NCT072846411 location
Understanding of Psychotic Disorders in Children With 22q11.2DS
NCT046393881 location
Early Scoliotic Changes in Children at Increased Risk for Scoliosis Development
NCT059243471 location